PRESS RELEASE published on 03/15/2023 at 13:30, 3 years 4 months ago Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities
PRESS RELEASE published on 03/13/2023 at 13:30, 3 years 4 months ago Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug
PRESS RELEASE published on 03/02/2023 at 14:30, 3 years 5 months ago Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
PRESS RELEASE published on 02/28/2023 at 14:30, 3 years 5 months ago FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
PRESS RELEASE published on 02/23/2023 at 14:30, 3 years 5 months ago Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
PRESS RELEASE published on 02/21/2023 at 14:30, 3 years 5 months ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 3 years 6 months ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 3 years 6 months ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 3 years 6 months ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 3 years 6 months ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
Published on 08/12/2026 at 15:42, 3 hours 37 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 3 hours 37 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 4 hours 19 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 4 hours 34 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 18:17, 1 hour 2 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/12/2026 at 18:15, 1 hour 4 minutes ago Shelly Group Delivers Strong Revenue and Earnings Growth in the First Six Months of 2026
Published on 08/11/2026 at 17:45, 1 day 1 hour ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 1 hour ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
